prostate cancer
Conditions
Interventions
count
 
serum 
f/t 
PSAD
MRI 
Sponsors
Peking University Third Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1.Blood 4ng/mL<PSA<50ng/mL; 2.routine prostate B-ultrasound examination; 3.patients who can cooperate with examination, treatment and agree to undergo prostate cancer biopsy; 4.age 18-85 years old; 5.patients sign "informed consent"
Exclusion criteria
Exclusion criteria: 1.Other malignant tumors diagnosed in the past 5 years; 2. unstable systemic diseases (active infection, uncontrolled hypertension, unstable angina pectoris, liver, kidney or metabolic diseases); 3.HIV-infected patients or patients with active hepatitis; 4.Those who have participated in other similar clinical trials in the past 30 days; 5.patients with mental illness, cognitive impairment, unable to understand the trial protocol, unable to complete the trial and follow-up work; 6. patients without personal freedom and independent civil capacity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood CTCs count;sensitivity, specificity, accuracy, AUC of ROC; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum PSA, f/t PSA;prostate multiparametric MRI scan;prostate B-ultrasound; | — |
Countries
China
Contacts
Public ContactZhang Shudong
Outcome results
None listed